Candida peritonitis

Minerva Anestesiologica

Volumn 80, Issue 4, 2014, Pages 470-481

  Hasibeder, W ^a   Halabi, M ^a  

^a Krankenhaus der Barmherzigen Schwestern Wien Betriebsgesellschaft   (Austria)

Author keywords

Antifungal agents; Candida; Critical illness; Intensive care; Peritonitis, surgery; Risk factors

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; VORICONAZOLE;

ABDOMINAL SURGERY; ANASTOMOSIS LEAKAGE; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; CANDIDA ALBICANS; CANDIDA PERITONITIS; CANDIDIASIS; FUNGAL COLONIZATION; HUMAN; LABORATORY DIAGNOSIS; MORTALITY; PERITONITIS; PREDICTIVE VALUE; REVIEW; RISK FACTOR; SEPTIC SHOCK; SYSTEMIC MYCOSIS; TOTAL PARENTERAL NUTRITION; TREATMENT OUTCOME; ULCER PERFORATION; DECISION TREE; MICROBIOLOGY;

CANDIDIASIS; DECISION TREES; HUMANS; PERITONITIS; RISK FACTORS;

EID: 84901386099     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmont MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. CID 2004;39:309-17. (Pubitemid 39050477)
2. Blot S, Vandewoude K. Management of invasive candidiasis in critically ill patients. Drugs 2004;64:2159-75. (Pubitemid 39382207)
3. Bougnoux ME, Kac G, Egerter P, dÈnfert C, Fagon JY, the CandiRea Study Group. Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome. Int Care Med 2008;34:292-9. (Pubitemid 351207637)
4. Blot SI, Vandewoude K, De Wele JJ. Candida peritonitis. Curr Opin Crit Care 2007;13:195-9. (Pubitemid 46328335)
5. Carneiro HA, Mavrakis A, Mylonakis E. Candida peritonitis: an update on the latest research and treatments. World J Surg 2011;35:2650-9.
6. Blot S, De Wele JJ, Vogelers D. Essentials for selecting antimicrobial therapy for intra-abdominal infections. Drugs 2012;72:el7-e32.
7. De Ruiter J, Weel J, Manusama E, Kingma WP, van der Voort PH. The epidemiology of intra-abdominal flora in critically ill patients with secondary and tertiary abdominal sepsis. Infection 2009;37:522-7.
8. Rex JH. Candida in the peritoneum: passenger or pathogen? Crit Care Med 2006;34:902-3.
9. Peoples JB. Candida and perforated peptic ulcers. Surgery 1986;100:758-64. (Pubitemid 16008848)
10. Sandven P, Qvist H, Skovlund E, Giercksky KE, the NOR-GAS group and the Norwegian Yeast Study Group. Significance of Candida recovered from the intraoperative specimens in patients with intra-abdominal perforations. Crit Care Med 2002;30:541-7. (Pubitemid 34214614)
11. Eggimann P, Bille J, Marchetti O. Diagnosis of invasive candidiasis in the ICU. Ann Int Care 2011;1:37.
12. Mean M, Marchetti O, Calandra T. Bench to bedside review: Candida infections in the intensive care unit. Crit Care 2008;12:R204.
13. Kami M, Machida U, Okuzumi K, Matsumura T, Mori Si S, Horia A et al. Effect of fluconazole prophylaxis on fungal blood cultures: an autopsy-based study involving 720 patients with hematologic malignancy. Br. J. Hematol 2002;1:40-6. (Pubitemid 34304419)
14. Dupont H, Paugam-Burtz C, Muller-Serieys C, Fierobe L, Chosidow D, Marmuse JP et al. Predictive factors of mortality to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients. Arch Surg 2002;137:1341-6.
15. Hughes MG, Chong TW, Smith RL, Evans HL, Pruett TL, Sawyer RG. Comparison of fungal and nonfungal infections in a broad-based surgical patient population. Surg Infect (Larchmt) 2005;6:55-64. (Pubitemid 40711365)
16. Montravers P, Dupont H, Gauzit R, Veber B, Auboyer C, Blin P et al. Candida as a risk factor for mortality in peritonitis. Crit Care Med 2006;34:646-52.
17. Lee SC, Fung CP, Chen HY, Li CT, Jwo SC, Hung YB, See LC et al. Candida peritonitis due to peptic ulcer perforation: incidence rate, risk factors, prognosis and susceptibility to fluconazole and amphotericin B. Diagn Microbiol Infect Dis 2002;44:23-7.
18. Sawyer RG, Rosenlof LK, Adams RB, May AK, Spengler MD, Pruett TL. Peritonitis into the 1990s: changing pathogens and changing strategies in the critically ill. Am Surg 1992;58:82-7.
19. Pappas PG, Rex JH, Lee J, Hamill RJ, Larsen RA, Powderly W et al. A prospective observational study on candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. CID 2003;37:634-43. (Pubitemid 37100802)
20. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994;220:751-8. (Pubitemid 24376373)
21. Albuquerque P, Casadevall A. Quorum sensing in fungi - a review. Med Mycol 2012;50:337-45.
22. De Sordi L, Mühlschlegel FA. Quorum sensing and fungal-bacterial interactions in candida albicans: a communicative network regulating microbial coexistence and virulence. FEMS Yeast Res 2009;9:990-9.
23. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med 1989;149:2349-53. (Pubitemid 19258182)
24. Solomkin JS. Timing of treatment for non-neutropenic patients colonized with Candida. Am J Surg 1996;172:44S-48S. (Pubitemid 27056959)
25. Dupont H, Bourichon A, Paugam-Burtz C, Mantz J, Desmonts JM. Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis? Crit Care Med 2003;31:752-7. (Pubitemid 36379578)
26. Cohen Y, Karoubi P, Adrie C, Gauzit R, Marsepoil T, Zarka D et al. Early prediction of Candida glabrata fungemia in non-neutropenic critically ill patients. Crit Care Med 2010;38:826-30.
27. Hernández MJ, Balaguer J, Armero R, Baldó J, Gómez L, Soalz C. Candida peritonitis: prevalence and risk factors. Rev Iberoam Micol 2012;19:1130-406.
28. Calandra T, Bille J, Schneider R, Mosimann F, Franciolo P. Clinical significance of Candida isolated from peritoneum in surgical patients. Lancet 1989;16:1437-40. (Pubitemid 20012067)
29. Cat TB, Charash W, Hebert J, Marden BT, Corbett SM, Ahern J et al. Potential influence of antisecretory therapy on the development of Candida-associated intra-abdominal infection. Ann Pharmacother 2008;42:185-91. (Pubitemid 351238565)
30. Hasibeder W, Torgersen Ch, Rieger M, Dünser MW. Critical care of the patient with acute pancreatitis. Anesth Intensive Care 2009;37:190-206.
31. Blinzler L, Fischer K, Just HM, Heuser D. Importance of mycoses in intraabdominal infections. Langenbecks Arch Chir 1997;382:S5-S8.
32. De Wele JJ. Rational use of antimicrobials in patients with severe acute pancreatitis. Semin Respir Crit Care Med 2011;32:174-80.
33. Hermsen ED, Zapapas M, Maiefski M, Rupp ME, Freifeld AG, Kalil AC. Validation and comparison of clinical prediction rules for invasive candidiasis in intensive care patients: a matched case-control study. Crit Care 2011;15:R198.
34. Leroy G, Lambiotte F, Thevenin D, Lemaire C, Parmentier E, Devos P, Leroy O. Evaluation of "Candida score" in critically ill patients: a prospective, multicenter, observational, cohort study. Ann Int Care 2011;1:50.
35. Petri MG, König J, Moecke HP, Gramm HJ, Barkow H, Kujath P et al. Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Int Care Med 1997;23:317-25. (Pubitemid 27129998)
36. Nathens AB, Rotstein OD, Marshall JC. Tertiary peritonitis: clinical features of a complex nosocomial infection. World J Surg 1998;22:158-63. (Pubitemid 28065182)
37. Shan YS, Hsu HP, Hsieh YH, Sy ED, Lee JC, Lin PW. Significance of intraoperative peritoneal culture of fungus in perforated peptic ulcer. Br J Surg 2003;90:1215-9. (Pubitemid 37330424)
38. Rutledge R, Mandel SR, Wild RE. Candida species: insignificant contaminant or pathogenetic species. Ann Surg 1983;198:299-302.
39. Comely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O et al. ESCMID guideline for the diagnosis and management of candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 2012;18:S19-S37.
40. Health Protection Agency. UK Standards for Microbiology Investigations - Investigation of continuous ambulatory peritoneal dialysis fluid. Bacteriology 2012; B25 Issue no 5.2:1-21
41. Health Protection Agency. UK Standards for Microbiology Investigations - Investigation of fluids from normally sterile sites. Bacteriology 2012; B26 Issue no 5.1: 1-24.
42. Guery BP, Arendrup MC, Auzinger G, Azoulay É, Borges M, Johnson EM et al. Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis. Int Care Med 2009;35:55-62.
43. Huang L, Zhang YY, Sun LY. Time to positivity of blood culture can predict different Candida species instead of pathogen concentration in candidemia. Eur J Clin Micobiol Infect Dis 2013 [Epub ahead of print].
44. Charles PE, Castro C, Ruiz-Santana S, Leon C, Saavedra P, Martin E. Serum procalcitonin levels in critically ill patients colonized with Candida spp: new clues for the early recognition of invasive candidiasis? Int Care Med 2009;32:2146-50.
45. Martini A, Gottin L, Menestrina N, Schweiger V, Simion D, Vincent JL. Procalcitonin levels in surgical patients at risk of candidemia. J Infect 2010;60:425-30.
46. Ostrosky-Zeichner L, Alexander BD, Kett DH, Vazquez J, Pappas PG, Seki F et al. Multicenter clinical evaluation of the (1 → 3) beta-D-glucan assay as an aid to diagnose fungal infections in humans. Clin Infect Dis 2005;41:654-9. (Pubitemid 41170353)
47. Fukuzawa Y. Antigenic structure of candida albicans. Immunological basis of the serologic specificity of the mannans in yeasts. Immunol Ser 1989;47:37-62.
48. Sendid B, Tabouret M, Poirot JL, Mathieu D, Fruit J, Poulain D. New enzyme immunoassays for sensitive detection of circulating candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis. J Clin Microbiol 1999;37:1510-7. (Pubitemid 29187827)
49. Moragues MD, Ortiz N, Iruretagoyena JR, Garzia-Ruiz JC, Amutio E, Rojas A et al. Evaluation of a new commercial test (Candida albicans IFA IgG) for the serodiagnosis of invasive candidiasis. Enferm Infecc Micobiol Clin 2004;22:83-8. (Pubitemid 38585446)
50. León C, Ruiz-Santana S, Saavedra P, Castro C, Úbeda A, Loza A et al. Value of β-D-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions. Int Care Med 2012;38:1315-25.
51. Mitsutake K, Miyazaki T, Tashiro T, Yamamoto Y, Kakeya H, Otsubo T et al. Enolase antigen, mannan antigen, Cand-Tec antigen, and beta-glucan in patients with candidemia. J Clin Microbiol 1996;34:1918-21. (Pubitemid 26239223)
52. Lain A, Elguezabal N, Brena S, Garcia-Ruiz JC, Del Palacio A, Moragues MD et al. Diagnosis of invasive candidiasis by enzyme-linked immunosorbent assay using the N-terminal fragment of Candida albicans hyphal wall protein 1. BMC Microbiol 2007;21:35.
53. Cuenca-Estrella M, Verweij PE, Arendrup MC, Arikan-Akdagli S, Bille J, Donnelly JP et al. ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect 2012;18:S9-S18.
54. Nguyen MH, Wissel MC, Shields RK, Salomoni MA, Hao B, Shields RM et al. Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis 2012;54:1240-8.
55. Playford EG, Webster AC, Sorrell TC, Craig JC. Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials. J Antimicrob Chemother 2006;57:628-38.
56. Schuster MG, Edwards JE, Sobel JD, Darouiche RO, Karchmer AW, Hadley S et al. Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial. Ann Intern Med 2008:149:83-90. (Pubitemid 352008596)
57. Harrison D, Muskett H, Harvey S, Grieve R, Shahin J, Patel K et al. Development and validation of a risk model for identification of non-neutropenic, critically ill adult patients at high risk of invasive candida infection: the Fungal Infection Risk Evaluation (FIRE) study. Health Technol Assess 2013;17:1-156.
58. Mulier S, Penninckx F, Verwesth C, Filez L, Erts R, Fieuws S et al. Factors affecting mortality in generalized postoperative peritonitis: multivariate analysis in 96 patients. World J Surg 2003;27:379-84. (Pubitemid 36920106)
59. Schneider CP, Seyboth C, Vilsmaier M, Küchenhoff H, Hofner B, Jauch KW, et al. Prognostic factors in critically ill patients suffering from secondary peritonitis: a retrospective, observational, survival time analysis. World J Surg 2009;33:34-43.
60. Swenson BR, Metzger R, Hedrick TL, McElearney ST, Evans HL, Smith RL et al. Choosing antibiotics for intra-abdominal infections: what do we mean by "high risk"? Surg Infect (Larchmt) 2009;10:29-39.
61. Eggimann P, Francoli P, Bille J, Schneider R, Wu MM, Chapuis G et al. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 1999;27:1066-72. (Pubitemid 29314312)
62. Spanakis EK, Aperis G, Mylonakis E. New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage. Clin Infect Dis 2006;43:1060-8. (Pubitemid 44631109)
63. Slavin MA, Sorell TC, Marriott D, Thursky KA, Nguyen Q, Ellis DH et al. Candidemia in adult cancer patients: risk for fluconazole-resistant isolates and death. J Antimicrob Chemother 2010;65:1042-51.
64. Kourkoumpetis TK, Velmahos GC, Ziakas PD, Tampakakis E, Manolakaki D, Coleman JJ et al. The effect of cumulative length of hospital stay on the antifungal resistance of candida strains isolated from critically ill surgical patients. Mycopathologica 2011;171:85-91.
65. Tan TY, Tan AL, Tee NVV, Ng LS. A retrospective analysis of antifungal susceptibilities of Candida bloodstream isolates from Singapore hospitals. Ann Acad Med Singapore 2008;37:835-40.
66. Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwars JE et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;48:503-35.
67. Kumar S, Bansal A, Chakrabarti A, Singhi S. Evaluation of efficiency of probiotics in prevention of candida colonization in a PICU-a randomized controlled trial. Crit Care Med 2013;41:565-72.
68. Rehman A, Heinsen FA, Koenen ME, Venema K, Knecht H, Hellmig S et al. Effects of probiotics and antibiotics on the intestinal homeostasis in a computer model of the large intestine. BMC Microbiol 2012;27:doi:10.